LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

Search

Revvity Inc

Cerrado

SectorSalud

90.4 -1.54

Resumen

Variación precio

24h

Actual

Mínimo

90.35

Máximo

90.8

Métricas clave

By Trading Economics

Ingresos

-53M

42M

Ventas

-65M

665M

P/B

Media del Sector

36.913

53.54

BPA

1.01

Rentabilidad por dividendo

0.31

Margen de beneficio

6.268

Empleados

11,000

EBITDA

-50M

173M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+30.59% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.31%

2.44%

Próximas Ganancias

28 jul 2025

Fecha Próximo Dividendo

8 ago 2025

Próxima Fecha de Ex Dividendo

18 jul 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-3.5B

11B

Apertura anterior

91.94

Cierre anterior

90.4

Noticias sobre sentimiento de mercado

By Acuity

21%

79%

54 / 381 Clasificación en Healthcare

Revvity Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

31 may 2025, 10:30 UTC

Principales Noticias

Pension Funds Won't Save the Bond Market -- Heard on the Street -- WSJ

31 may 2025, 06:30 UTC

Ganancias

5 Things We've Learned From Retail Earnings -- Barrons.com

31 may 2025, 04:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

30 may 2025, 23:51 UTC

Adquisiciones, fusiones, absorciones

Trump Raises Steel Tariffs, Saying U.S. Steel Will Remain U.S.-Controlled -- Update

30 may 2025, 21:30 UTC

Principales Noticias

Stocks Shrug Off Trade War to Post Best Month Since 2023 -- WSJ

30 may 2025, 21:15 UTC

Principales Noticias

The Score: E.l.f. Beauty, Tesla, Nvidia, and More Stocks That Defined the Week -- WSJ

30 may 2025, 20:50 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Health Care Roundup: Market Talk

30 may 2025, 20:44 UTC

Adquisiciones, fusiones, absorciones

Bill Ackman Is Killing It. A New ETF Will Track His Investments. -- Barrons.com

30 may 2025, 20:24 UTC

Principales Noticias

Major U.S. Stock Indexes Finish About Flat; U.S.-China Trade Friction Renews -- WSJ

30 may 2025, 20:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

30 may 2025, 19:44 UTC

Charlas de Mercado

Gold Breaks 4-Month Winning Streak -- Market Talk

30 may 2025, 19:38 UTC

Charlas de Mercado

Companies Delay or Cancel $14B In Clean-Energy Investments -- Market Talk

30 may 2025, 19:29 UTC

Ganancias
Adquisiciones, fusiones, absorciones

NRG Energy and UnitedHealth Are the S&P 500's Best and Worst for May. Here's Why. -- Barrons.com

30 may 2025, 19:14 UTC

Charlas de Mercado

Oil Settles Lower Ahead of OPEC+ Output Decision -- Market Talk

30 may 2025, 19:05 UTC

Charlas de Mercado

U.S. Natural Gas Futures Fall Awaiting Hotter Weather -- Market Talk

30 may 2025, 18:51 UTC

Charlas de Mercado

Canada's Retaliatory Tariffs Help Fuel Sizable Rise in Tax Revenue -- Market Talk

30 may 2025, 18:37 UTC

Charlas de Mercado
Ganancias

Costco Well Positioned for Sustainable Growth, UBS Says -- Market Talk

30 may 2025, 18:04 UTC

Principales Noticias

S&P 500 Falls After More Trump-China Friction -- WSJ

30 may 2025, 17:47 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

30 may 2025, 17:47 UTC

Charlas de Mercado

Time for BoC Gov. Macklem to Cut Rates, Desjardins Says -- Market Talk

30 may 2025, 17:40 UTC

Adquisiciones, fusiones, absorciones

Trump Is Praising His U.S. Steel Deal. No One Is Sure What It Means -- WSJ

30 may 2025, 17:38 UTC

Charlas de Mercado

U.S: Oil Rig Count Falls for Fifth Straight Week -- Market Talk

30 may 2025, 17:31 UTC

Charlas de Mercado

Costco Well Positioned to Gain Share Amid Tariffs, Baird Says -- Market Talk

30 may 2025, 17:14 UTC

Principales Noticias

American Consumers Are Still Gloomy on the Economy -- 3rd Update

30 may 2025, 16:31 UTC

Ganancias

Ulta Beauty Stock Is Rising. Earnings Strength Was More Than Cosmetic. -- Barrons.com

30 may 2025, 16:20 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

30 may 2025, 16:20 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Health Care Roundup: Market Talk

30 may 2025, 16:16 UTC

Principales Noticias

S&P 500 Falls After Trump Hits Out at China -- WSJ

30 may 2025, 16:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

30 may 2025, 16:14 UTC

Principales Noticias

HSBC Retreats From Banking Smaller U.S. Businesses -- WSJ

Comparación entre iguales

Cambio de precio

Revvity Inc Esperado

Precio Objetivo

By TipRanks

30.59% repunte

Estimación a 12 meses

Media 118.08 USD  30.59%

Máximo 135 USD

Mínimo 100 USD

De acuerdo con 14 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Revvity Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

14 ratings

9

Comprar

5

Mantener

0

Vender

Sentimiento

By Acuity

54 / 381 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Revvity Inc

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.